tissue. We identified significant association of a multi-allelic CNV encompassing the salivary amylase gene (AMY1) with body mass index (BMI) and obesity, and we replicated this finding in 6,200 subjects. Increased AMY1 copy number was positively associated with both amylase gene expression (P = 2.31 × 10 −14 ) and serum enzyme levels (P < 2.20 × 10 −16 ), whereas reduced AMY1 copy number was associated with increased BMI (change in BMI per estimated copy = −0.15 (0.02) kg/m 2 ; P = 6.93 × 10 −10 ) and obesity risk (odds ratio (OR) per estimated copy = 1.19, 95% confidence interval (CI) = 1.13-1.26; P = 1.46 × 10 −10 ). The OR value of 1.19 per copy of AMY1 translates into about an eightfold difference in risk of obesity between subjects in the top (copy number > 9) and bottom (copy number < 4) 10% of the copy number distribution. Our study provides a first genetic link between carbohydrate metabolism and BMI and demonstrates the power of integrated genomic approaches beyond genome-wide association studies.
Common multi-allelic copy number variants (CNVs) appear enriched for phenotypic associations compared to their biallelic counterparts [1] [2] [3] [4] . Here we investigated the influence of gene dosage effects on adiposity through a CNV association study of gene expression levels in adipose tissue. We identified significant association of a multi-allelic CNV encompassing the salivary amylase gene (AMY1) with body mass index (BMI) and obesity, and we replicated this finding in 6,200 subjects. Increased AMY1 copy number was positively associated with both amylase gene expression (P = 2.31 × 10 −14 ) and serum enzyme levels (P < 2.20 × 10 −16 ), whereas reduced AMY1 copy number was associated with increased BMI (change in BMI per estimated copy = −0.15 (0.02) kg/m 2 ; P = 6.93 × 10 −10 ) and obesity risk (odds ratio (OR) per estimated copy = 1.19, 95% confidence interval (CI) = 1.13-1.26; P = 1.46 × 10 −10 ). The OR value of 1.19 per copy of AMY1 translates into about an eightfold difference in risk of obesity between subjects in the top (copy number > 9) and bottom (copy number < 4) 10% of the copy number distribution. Our study provides a first genetic link between carbohydrate metabolism and BMI and demonstrates the power of integrated genomic approaches beyond genome-wide association studies.
We designed a gene-centric association study (GCAS) to identify common CNVs overlapping genes and inducing a dosage-dependent effect on gene expression, hypothesizing that these loci might be Low copy number of the salivary amylase gene predisposes to obesity enriched for physiologically relevant CNVs. To achieve this aim, we conducted a family-based association analysis of signal intensity data from DNA arrays (log R ratio and B-allele frequency) with transcriptomic data from adipose tissue using famCNV 5 in 149 Swedish families ascertained through the identification of siblings who were discordant for obesity 6 (Fig. 1, Table 1 and Supplementary Fig. 1) . A total of 76 probes that hybridize within putative CNVs showed a dosage-dependent effect on gene expression at a false discovery rate (FDR) of 1% ( Supplementary Table 1 ). Of these probes, only cnvi0020639, mapping to a CNV overlapping the amylase gene cluster (including the AMY1 salivary amylase gene and the AMY2 pancreatic amylase gene, expression probe set 208498_s_at; FDR = 6.88 × 10 −3 ), was also associated with adiposity (both BMI (P = 3.86 × 10 −4 ) and fat mass (P = 3.11 × 10 −4 )) ( Supplementary Figs. 2-4) . Salivary amylase is encoded by the three distinct but closely related genes, AMY1A, AMY1B and AMY1C, which are referred to collectively here as AMY1. Analogously, except where otherwise noted, AMY2 refers to the pancreatic amylase gene cluster encompassing the genes AMY2A and AMY2B. Reduced signal intensity at this probe, indicative of reduced copy number at this locus, was associated with increased adiposity (Fig. 2 , Table 2 and Supplementary Figs. 2-4) .
This inverse association between copy number in the amylase region and BMI was first replicated using signal intensity data from DNA arrays in 972 subjects from TwinsUK ( Table 1) 7 . The strongest association was observed at cnvi0022844 (P = 1.13 × 10 −3 ; Table 2 ), which showed significant association with BMI after Bonferroni correction. When multiple probes were considered through principal-component analysis, the BMI association signal actually extended over a region between the hybridization sites for cnvi0022844 and cnvi0016754 (P = 1.32 × 10 −3 ), which overlapped the cnvi0020639 probe site associated with adiposity in the Swedish discovery families. These results, although supportive of the association in the amylase region, did not permit us to distinguish which of the salivary or pancreatic amylase genes was driving the association with adiposity, necessitating the use of a non-array-based method of copy number measurement.
Consequently, we estimated copy number at AMY1 and AMY2 in 481 subjects from the Swedish families ( Table 1) using quantitative PCR (qPCR). This approach generates a continuous intensity distribution from which integer copy numbers can be inferred by comparison to a reference sample of known copy number (Supplementary Note). Given the many technical challenges inherent in copy number measurement at multi-allelic loci 2,8-11 , we treated these discretized measurements as relative estimates or surrogates correlated with the true underlying copy number state rather than absolute copy number genotypes.
Only three estimated copy number states (1-3) were detected for the pancreatic amylase gene (AMY2), and these were not associated with either BMI or fat mass ( Supplementary Table 2 ). In contrast, copy number estimates at AMY1 ranged from 2 to 14 and showed association with both BMI (P = 8.08 × 10 −3 ) and fat mass (P = 8.53 × 10 −3 ), confirming our previous DNA array-based analysis ( Supplementary  Table 2 ). We found greater correlation between signal intensity at cnvi0020639 and AMY1 copy number (r = 0.73; P < 2.20 × 10 −16 ) than with AMY2 copy number (r = 0.35; P = 1.25 × 10 −8 ), suggesting that the GCAS-identified association was mainly capturing copy number variation at AMY1 rather than AMY2 and justifying follow-up of the former. Furthermore, we validated the accuracy of the AMY1 qPCR assay by using AMY1 copy number estimates derived from whole-genome shotgun sequencing data for the 1000 Genomes Project 12 and observed a correlation of 0.94 (P < 2.20 × 10 −16 ) between AMY1 copy number estimates derived by qPCR and sequencing (Supplementary Figs. 5-8 and Supplementary Table 3 ). To further validate the AMY1 qPCR assay, we also compared copy number measured by qPCR in 96 samples from the French Data from the Epidemiological Study on the Insulin Resistance syndrome (DESIR) cohort 13 with AMY1 copy number measured by digital PCR in the same samples, obtaining high correlation between the two methods (r = 0.95; P < 2.20 × 10 −16 ; Supplementary Fig. 9 ). Analogously, high correlation (r = 0.98; P < 2.20 × 10 −16 ; Supplementary Fig. 9 ) was also observed between copy numbers measured using the qPCR assay applied in this study and copy numbers obtained using a different qPCR assay on the same 96 DESIR samples.
To replicate the observed association in a larger sample, we next estimated AMY1 copy number by qPCR in an additional sample of 1,479 female subjects from TwinsUK 14 and 2,137 male and female subjects from DESIR 13 ( Table 1 ). The two population samples showed a similar copy number distribution (Wilcoxon test P > 0.05) with estimated median copy number of 6, ranging from 1 to 18 ( Supplementary Fig. 10 and Supplementary Tables 4 and 5). Metaanalysis of AMY1 effects in TwinsUK and DESIR (total n = 3,616) showed significant association between reduced AMY1 copy number and increased BMI (per-copy β (se) = −0.15 (0.02) kg/m 2 ; P = 6.93 × 10 −10 ; Fig. 3 , Table 2 and Supplementary Tables 6-9). Results of associations assessed using both the qPCR intensity signal as a continuous measure as well as discretized using an unsupervised Figure 1 Manhattan plot of gene-centric CNV association study (GCAS) results with gene expression levels in subcutaneous adipose tissue using data from the Swedish family study. The chromosomal location for each probe is given on the x axis for each of the 22 autosomes, and −log 10 (P) of the association between probe signal intensity and gene expression levels is shown on the y axis. The inset depicts the amylase region. The probes tested against amylase gene transcriptional levels are shown in green. l e t t e r s npg l e t t e r s clustering approach (k means) were concordant with those generated using integer copy numbers (Supplementary Note).
We then assessed the effect of AMY1 copy number on obesity susceptibility by selecting obese cases (BMI ≥ 30 kg/m 2 ) and normalweight controls (BMI < 25 kg/m 2 ) from TwinsUK and DESIR and by measuring AMY1 copy number by qPCR in an additional 205 severely obese cases and 358 age-matched controls from the French Adult Obesity (AOB) 15 study ( Table 1 and Supplementary Note). In these European samples, subjects with lower estimated AMY1 copy number showed significantly increased risk of obesity in each of the three samples (meta-analysis per estimated AMY1 copy number: OR = 1.19, 95% CI = 1.13-1.26; P = 1.46 × 10 −10 ; Fig. 3 and Table 2 ). The AMY1 copy number distribution in our sample ranged from 1 to 18 copies, with approximately 10% of subjects carrying fewer than 4 copies of AMY1 and 10% of subjects carrying an AMY1 copy number greater than 9 ( Table 2) . Given the multi-allelic nature of the AMY1 CNV, this OR of 1.19 per copy of AMY1 translates into about an eightfold difference in risk of obesity between subjects in the top (copy number > 9) and bottom (copy number < 4) deciles of the distribution of estimated AMY1 copy numbers (OR = 7.67, 95% CI = 3.92-14.99; P = 2.52 × 10 −9 ; Supplementary Table 10 ). Using a multifactorial liability threshold model 16 , we estimated the proportion of total variance in obesity explained by estimated AMY1 copy number to lie between 1.73 and 7.94% (95% CI; Supplementary  Table 11 ). Therefore, on the basis of an estimated heritability of 40-70% for obesity 17, 18 , copy number variation at AMY1 may account for 2.47-19.86% of the total genetic variation in obesity. Analogously, we estimated that between 0.66 and 4.40% of the proportion of genetic variance in BMI could be explained by inferred AMY1 copy number in these European samples.
As all the samples included in our analyses were of European origin, we reasoned that replication in a sample of different ancestry under differing environmental influences on obesity would provide greater support for its physiological role. We therefore selected a Singaporean Figure 2 The amylase region in detail. Top, famCNV association results between signal intensity for probes mapping within 30 kb of the amylase cluster and amylase expression levels (probe set 208498_s_at) in adipose tissue in the Swedish family discovery study, with chromosomal coordinates given on the x axis and −log 10 (P) on the y axis. Middle, locations of hybridization sites for probes showing association between signal intensity and BMI: cnvi0020639 (blue; Swedish family discovery study) and cnvi0022844 (red; TwinsUK). Because of the repetitive nature of this region, which contains six paralogs (including one pseudogenized copy) in the reference genome (supplementary Fig. 13 ), the cnvi0020639 and cnvi0022844 probes were found to map to two locations each within the amylase gene cluster. Gene content in the amylase region, based on the human reference sequence (hg19; RefSeq), depicting AMY2B, AMY2A and the AMY1A, AMY1B and AMY1C genes, as well as two segmental duplications with high sequence similarity in the region. Bottom, LD between HapMap markers (release 23) calculated with Haploview 46 (darker shading corresponds to higher r 2 value). 19 . A total of 136 obese and 197 overweight subjects were identified among the 2,431 Chinese subjects included in the SP2 cohort, with 325 matched lean Chinese SP2 normal-weight controls. AMY1 copy number was measured by qPCR in all 658 subjects. Median copy number in SP2 normal-weight subjects was 6 (ranging from 2 to 16), similar to in our French DESIR and UK TwinsUK populations and in line with previous observations by Perry et al. 20 .
Case-control association analysis in the Chinese sample showed that reduced estimated copy number for AMY1 was associated with increased risk of obesity (per-copy OR = 1.17, 95% CI = 1.05-1.29; P = 3.73 × 10 −3 ). Extending the case sample to include the 197 overweight subjects further confirmed the results (per-copy OR = 1.13, 95% CI = 1.06-1.21; P = 3.52 × 10 −4 ). To validate our AMY1 genomic copy number data at the protein level, we investigated the effect of copy number variation at AMY1 and AMY2 on serum amylase enzyme levels and their relationship with BMI using 468 French morbidly obese subjects from the Atlas Biologique de l'Obésité Sévère (ABOS) study ( Table 1 and Supplementary Table 12 ). On average, salivary and pancreatic amylase proportions were approximately equal in serum (52% and 48%, respectively), and their levels showed close positive association with copy number variation at their respective genes (P < 2.20 × 10 −16 and 1.04 × 10 −11 , respectively; Supplementary Fig. 11 ). BMI was inversely associated with serum salivary amylase levels (β = −0.23 (0.04) kg/m 2 ; P = 2.26 × 10 −7 ; Supplementary Fig. 12 ) and to a lesser extent with serum pancreatic amylase levels (β (se) = −0.23 (0.06) kg/m 2 ; P = 2.29 × 10 −4 ; Supplementary Fig. 12) , likely reflecting the physiological correlation between the levels of the two enzymes (r = 0.21; P = 4.29 × 10 −6 ). Salivary amylase catalyzes the hydrolysis of the α-1,4-glycosidic bonds of starch, initiating carbohydrate digestion in the oral cavity. Whereas individual salivary amylase levels vary in response to environmental factors, including psychological stress 21 , they are genetically influenced by and directly correlate with the highly variable copy number at AMY1 (refs. 20, 22) . Higher gene copy numbers at this locus are believed to have evolved in the human lineage as a consequence of a shift to a starch-rich diet 23 . Human populations traditionally consuming a high proportion of carbohydrates in their diet show higher copy numbers and salivary amylase activity than those consuming a low-starch diet 20, 24 . The salivary glands and pancreas make similar contributions to the determination of overall levels of serum amylase 25 , although enzyme activity is also detectable in other organs, including in adipose tissue 26, 27 . Indeed, AMY1 was among the 30% most highly expressed genes in adipose tissue in both our discovery sample and publicly available data from an unselected population sample, thus suggesting that this gene is actively expressed in adipose tissue (Supplementary Note). Whether adipose tissue is functionally involved in the link between AMY1 copy number and obesity or whether this link implicates a different tissue in which AMY1 is also actively transcribed warrants further investigation.
Lower blood amylase levels have been observed in both obese humans 28 and rats 29 and have recently been associated with increased risk of metabolic abnormalities 30, 31 and reduced preabsorptive insulin release 32 . Furthermore, a recent study in mice fed a high-fat and high-sugar diet suggested association of the amylase locus with weight gain 33 . In these mice, this locus was also shown to be associated with the proportion of Enterobacteriaceae in the gut microbiota 33 , which have previously been correlated with obesity in humans 34 . npg l e t t e r s Rare CNVs have recently been implicated in highly penetrant forms of obesity 35, 36 and severe thinness 37 through gene dosage-dependent effects. Common biallelic CNVs have also been associated with BMI [38] [39] [40] [41] ; however, as most of these CNVs are reliably tagged by surrounding SNPs 42 , they share the same properties of small effect size and limited predictive value for obesity risk. In contrast, complex multi-allelic CNVs show lower linkage disequilibrium (LD) with surrounding SNPs ( Supplementary Table 13 ) and are consequently less detectable by SNP-based genome-wide association study (GWAS) 43 . Surprisingly, FTO is the most replicated obesity susceptibility gene identified through GWAS 41 , yet, in our analyses, estimated AMY1 copy number appeared to show stronger association with BMI than FTO SNPs (Supplementary Tables 14 and 15) . It is conceivable that high structural variability in the amylase region and subsequent low SNP coverage (Supplementary Figs. 13-15 ) might have hampered previous SNP-based GWAS attempts to detect association between the amylase cluster and adiposity. Indeed, examination of data from the most recent meta-analysis for BMI conducted by the Genetic Investigation of ANthropometric Traits (GIANT) Consortium 41 showed a large gap in SNP coverage across the locus encompassing the salivary amylase gene (Supplementary Fig. 14) .
Present DNA high-throughput methods for CNV assessment, including array-, PCR-and sequencing-based approaches, are all affected by a wide number of variables, including DNA source, extraction method, quality and concentration, as well as experimental factors, inducing batch effects 10, 11, 44 . These factors complicate copy number measurement at multi-allelic CNVs and hinder the pooling of data from multiple centers. The observed association of AMY1 with obesity may rekindle interest in the role of multi-allelic CNVs in common disease, driving the development of novel technological approaches for the accurate and high-throughput measurement of absolute copy number at such loci. These technological improvements will enable high-quality association analyses at such loci in larger sample sizes similar to those included in SNP association studies and are mandatory for disease risk assessment at the individual level, paving the way toward personalized medicine.
Our study provides a first genetic link between carbohydrate metabolism and obesity, with low copy number at AMY1 resulting in decreased salivary amylase levels and a higher risk of obesity. This finding provides intriguing insight into some of the biological mechanisms underlying obesity, as well as a novel rationale for the investigation of innovative obesity treatments based on the manipulation of digestive enzyme levels.
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Methods and any associated references are available in the online version of the paper.
Accession codes. Gene expression microarray data for the complete Swedish discordant sibling pair study sample have been deposited in the Gene Expression Omnibus (GEO) under accession GSE27916.
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